223 related articles for article (PubMed ID: 28088278)
1. Metabolomic analysis of urine samples by UHPLC-QTOF-MS: Impact of normalization strategies.
Gagnebin Y; Tonoli D; Lescuyer P; Ponte B; de Seigneux S; Martin PY; Schappler J; Boccard J; Rudaz S
Anal Chim Acta; 2017 Feb; 955():27-35. PubMed ID: 28088278
[TBL] [Abstract][Full Text] [Related]
2. [Urine metabolomics analysis based on ultra performance liquid chromatography-high resolution mass spectrometry combined with osmolality calibration sample concentration variability].
He Z; Lin H; Gui J; Zhu W; He J; Wang H; Feng L
Se Pu; 2021 Apr; 39(4):391-398. PubMed ID: 34227759
[TBL] [Abstract][Full Text] [Related]
3. Use of a pre-analysis osmolality normalisation method to correct for variable urine concentrations and for improved metabolomic analyses.
Chetwynd AJ; Abdul-Sada A; Holt SG; Hill EM
J Chromatogr A; 2016 Jan; 1431():103-110. PubMed ID: 26755417
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dilution and normalization strategies to correct for urinary output in HPLC-HRTOFMS metabolomics.
Vogl FC; Mehrl S; Heizinger L; Schlecht I; Zacharias HU; Ellmann L; Nürnberger N; Gronwald W; Leitzmann MF; Rossert J; Eckardt KU; Dettmer K; Oefner PJ;
Anal Bioanal Chem; 2016 Nov; 408(29):8483-8493. PubMed ID: 27815612
[TBL] [Abstract][Full Text] [Related]
5. Osmolality-based normalization enhances statistical discrimination of untargeted metabolomic urine analysis: results from a comparative study.
Mervant L; Tremblay-Franco M; Jamin EL; Kesse-Guyot E; Galan P; Martin JF; Guéraud F; Debrauwer L
Metabolomics; 2021 Jan; 17(1):2. PubMed ID: 33389209
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.
Cook T; Ma Y; Gamagedara S
J Pharm Biomed Anal; 2020 Jan; 177():112854. PubMed ID: 31518861
[TBL] [Abstract][Full Text] [Related]
7. Normalization strategies for metabonomic analysis of urine samples.
Warrack BM; Hnatyshyn S; Ott KH; Reily MD; Sanders M; Zhang H; Drexler DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):547-52. PubMed ID: 19185549
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies.
Kamleh MA; Ebbels TM; Spagou K; Masson P; Want EJ
Anal Chem; 2012 Mar; 84(6):2670-7. PubMed ID: 22264131
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD.
Khamis MM; Holt T; Awad H; El-Aneed A; Adamko DJ
Metabolomics; 2018 Aug; 14(9):115. PubMed ID: 30830407
[TBL] [Abstract][Full Text] [Related]
10. Combination of injection volume calibration by creatinine and MS signals' normalization to overcome urine variability in LC-MS-based metabolomics studies.
Chen Y; Shen G; Zhang R; He J; Zhang Y; Xu J; Yang W; Chen X; Song Y; Abliz Z
Anal Chem; 2013 Aug; 85(16):7659-65. PubMed ID: 23855648
[TBL] [Abstract][Full Text] [Related]
11. Towards Standardization of Data Normalization Strategies to Improve Urinary Metabolomics Studies by GC×GC-TOFMS.
Nam SL; Mata AP; Dias RP; Harynuk JJ
Metabolites; 2020 Sep; 10(9):. PubMed ID: 32961779
[TBL] [Abstract][Full Text] [Related]
12. Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping.
Lewis MR; Pearce JT; Spagou K; Green M; Dona AC; Yuen AH; David M; Berry DJ; Chappell K; Horneffer-van der Sluis V; Shaw R; Lovestone S; Elliott P; Shockcor J; Lindon JC; Cloarec O; Takats Z; Holmes E; Nicholson JK
Anal Chem; 2016 Sep; 88(18):9004-13. PubMed ID: 27479709
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Effect of Data Merging and Postacquisition Normalization on Statistical Analysis of Untargeted High-Resolution Mass Spectrometry Based Urinary Metabolomics Data.
Brix F; Demetrowitsch T; Jensen-Kroll J; Zacharias HU; Szymczak S; Laudes M; Schreiber S; Schwarz K
Anal Chem; 2024 Jan; 96(1):33-40. PubMed ID: 38113356
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of intensity drift correction strategies using MetaboDrift, a normalization tool for multi-batch metabolomics data.
Thonusin C; IglayReger HB; Soni T; Rothberg AE; Burant CF; Evans CR
J Chromatogr A; 2017 Nov; 1523():265-274. PubMed ID: 28927937
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
16. Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry.
González-Domínguez R; Castilla-Quintero R; García-Barrera T; Gómez-Ariza JL
Anal Biochem; 2014 Nov; 465():20-7. PubMed ID: 25064643
[TBL] [Abstract][Full Text] [Related]
17. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
[TBL] [Abstract][Full Text] [Related]
18. A method for comparative metabolomics in urine using high resolution mass spectrometry.
Ramakrishnan P; Nair S; Rangiah K
J Chromatogr A; 2016 Apr; 1443():83-92. PubMed ID: 27012786
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Profiling of Human Urine Samples Using LC-TIMS-QTOF Mass Spectrometry.
Di Poto C; Tian X; Peng X; Heyman HM; Szesny M; Hess S; Cazares LH
J Am Soc Mass Spectrom; 2021 Aug; 32(8):2072-2080. PubMed ID: 34107214
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
